Skip to the page

Data / Form D filings / aMBR Genomics, Inc.

aMBR Genomics, Inc.: Form D filing

aMBR Genomics, Inc., a health care company in Madison, WI, filed a Form D with the SEC in 2026. The latest, on March 31, 2026, reports $1.1 million sold of a $2 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
504 S. ROSA ROAD SUITE 200, Madison, WI, 53719
Phone
(608) 695-7100
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2098331

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 31, 2026New notice$2,000,000$1,100,000$900,0004Oct 21, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Ahna SkopExecutive Officer, Director
Eugene YeoExecutive Officer, Director
Michael MoserExecutive Officer

Other health care companies in Wisconsin that filed recently

Every Form D from the week of Mar 30, 2026 · All recent filings in Wisconsin · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what aMBR Genomics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.